Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Quality Assurance: SOP for Root Cause Analysis in Gels Production

Posted on By

SOP for Root Cause Analysis in Gels Production

Standard Operating Procedure for Root Cause Analysis in Gels Production

1) Purpose

The purpose of this SOP is to establish procedures for conducting effective root cause analysis (RCA) of deviations, non-conformances, or quality issues encountered during gels production, aiming to identify underlying causes and implement corrective actions to prevent recurrence.

2) Scope

This SOP applies to all personnel involved in the pharmaceutical manufacturing facility’s gels production department, including Quality Assurance (QA), Quality Control (QC), Production, and Engineering personnel responsible for RCA activities.

3) Responsibilities

Quality Assurance (QA) Team: Oversee RCA process and ensure compliance with SOPs.
Quality Control (QC) Analysts: Perform initial data collection and investigation of deviations.
Production Supervisors: Provide operational insights and support RCA investigations.
Engineering Team: Assist in identifying equipment-related root causes and implementing corrective actions.

See also  SOP for Quality Control Sample Management

4) Procedure

4.1 Deviation Identification and Documentation
4.1.1 Identify and document deviations, non-conformances, or quality issues that require RCA based on established criteria.
4.1.2 Classify the issue based on severity, impact on product quality, and potential regulatory implications.

4.2 RCA Team Formation
4.2.1 Form an RCA team comprising multidisciplinary members with relevant expertise and knowledge related to the issue.
4.2.2 Designate a team leader responsible

for coordinating RCA activities and ensuring timely completion.

4.3 Data Collection and Analysis
4.3.1 Gather relevant data, including production records, laboratory results, equipment logs, and any other pertinent information.
4.3.2 Analyze collected data to identify patterns, trends, or anomalies that may indicate potential root causes.

See also  Quality Assurance: SOP for Label Inspection for Gels

4.4 Root Cause Identification
4.4.1 Utilize structured RCA techniques (e.g., Fishbone diagram, 5 Whys) to systematically identify underlying root causes of the issue.
4.4.2 Prioritize and verify potential root causes based on data analysis and team consensus.

4.5 Corrective and Preventive Actions (CAPA)
4.5.1 Develop and propose appropriate corrective actions to address identified root causes and prevent recurrence.
4.5.2 Obtain approval from designated personnel, such as QA Manager or Production Manager, for implementation of CAPAs.

4.6 Implementation and Follow-Up
4.6.1 Implement approved corrective actions promptly and effectively, ensuring they are documented and communicated to relevant stakeholders.
4.6.2 Monitor the effectiveness of implemented CAPAs through follow-up activities and periodic reviews.

See also  Quality Assurance: SOP for Handling Deviations

5) Abbreviations, if any

SOP: Standard Operating Procedure
RCA: Root Cause Analysis
QA: Quality Assurance
QC: Quality Control
CAPA: Corrective and Preventive Actions

6) Documents, if any

– RCA Investigation Report Form
– Root Cause Analysis Reports
– Corrective and Preventive Action (CAPA) Plans and Reports

7) Reference, if any

– FDA Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
– ISO 9001:2015 Quality management systems – Requirements
– Company-specific RCA procedures and guidelines

8) SOP Version

Version 1.0

Quality Assurance Tags:Analytical Method Development for Gels, Assay of Active Ingredient in Gels, Cleaning Equipment for Gel Production, Contamination Prevention in Gel Manufacturing, Equipment Calibration for Gel Manufacturing, Final Product Inspection for Gels, Gel Formulation Development, Gel Homogeneity Testing, Gel Labeling Procedures, Gel Preparation SOP, Gel Production Documentation, Gel Production Waste Disposal, Gel Quality Control Testing, Gel Viscosity Testing, In-process Testing for Gels, Microbial Testing of Gels, Packaging of Gels, Particle Size Analysis in Gels, Particle Size Distribution in Gels, pH Testing of Gels, Pharmaceutical Gel Manufacturing, Process Optimization for Gel Manufacturing, Process Validation for Gels, Raw Material Inspection for Gels, Rheological Testing in Gels, Sample Collection for Gel Quality Testing, Stability Testing for Gels, Sterility in Gel Production, Storage Conditions for Gels, Training for Gel Production Personnel

Post navigation

Previous Post: SOP for Emulsion Stability Testing in Gels
Next Post: Quality Assurance: SOP for Corrective and Preventive Actions (CAPA) in Gels Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version